Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort studyBMJ 2000; 321 doi: http://dx.doi.org/10.1136/bmj.321.7259.483 (Published 19 August 2000) Cite this as: BMJ 2000;321:483
- Urban Ösby (), consultanta,
- Nestor Correiab, associate professor,
- Lena Brandta, researcher,
- Anders Ekbomb, professor,
- Pär Sparén, associate professorb
- a Department of Clinical Neuroscience, Karolinska Institute, S-171 76 Stockholm, Sweden
- b Department of Medical Epidemiology, Karolinska Institute
- Correspondence to: U Ösby
- Accepted 4 May 2000
Although mortality in patients with schizophrenia is two to three times higher than that in the general population, little is known about time trends in mortality rates.1-3 We aimed to assess mortality over time after a first admission to hospital with schizophrenia. In those patients who died, the cause of death was categorised as natural, cardiovascular, suicide, or unspecified violence.
Subjects, methods, and results
The Swedish patient register details all psychiatric inpatient treatments since 1 January 1971. Data on residents of Stockholm County (population 1.8 million) whose first admission to hospital with a diagnosis of schizophrenia had occurred between 1976 and 1995 were linked to the national causes of death register, and the date and underlying cause of death were determined in those who had died. Because mortality—and particularly mortality from suicide—is increased in the period after a first admission to hospital,1-3 we confined our study to these patients and excluded any who had been diagnosed before 1976. Follow up (in person years) was calculated in relation to sex, five year age group, five year age group and social class, and five year calendar period from the date of a first admission to hospital with schizophrenia to 31 December 1995 or death, whichever occurred first. The expected number of deaths was estimated from mortality rates for the general Stockholm population between 1976 and 1995. Standardised mortality ratios for natural, unnatural, and specific causes of death were calculated for each five year period. Relative excess death risks were estimated through Poisson regression models, controlling for age at diagnosis and length of follow up when appropriate.
Standardised mortality ratios for all causes of death increased 1.7-fold in men and 1.3-fold in women over the study period. The increase was greatest in 1991–5 for men and in 1981–5 for women. Death from cardiovascular causes increased 4.7-fold in men and 2.7-fold in women; suicide increased 1.6-fold in men and 1.9-fold in women; and mortality from unspecified violence increased 3.8-fold in men and 3.4-fold in women (table).
Our data indicate increasing mortality among people with schizophrenia. Standardised mortality ratios increased over time for all causes of death, but the appreciable increases in deaths from natural and cardiovascular causes suggest that the somatic health of these patients deteriorated, perhaps because their illness causes them to adopt an unhealthy lifestyle and to be less inclined to seek health care.4 High mortality from suicide in schizophrenia patients was also reported in a registry linked study from Denmark.3 Mortality from unspecified violence in our study may include cases of suicide.
The changing criteria for hospital admission during the study period meant that proportionately more patients with severe illness were admitted; this represents a potential confounding factor. However, the number of patients admitted to hospital with schizophrenia increased over this time, arguing against the occurrence of selection bias. Diagnostic specificity is another concern, but validation based on medical records of clinical schizophrenia diagnoses in Stockholm County estimated that 80%-85% of these met the operational diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, third edition, revised.5
During the study period there were important changes in psychiatric care offered to patients with schizophrenia: outpatient treatment replaced long term inpatient care. In Stockholm between 1976 and 1994, the number of hospital bed days associated with schizophrenia fell by 64%, and this reduction in beds is the most probable explanation for the rising mortality. The same conclusion was drawn in a Danish study reporting increasing mortality from suicide.3 Our findings emphasise the importance of monitoring trends in mortality for patients with schizophrenia as well as for other patient groups as indicators of outcome and quality of psychiatric and medical care.
Contributors: UÖ had the original idea for the study, coordinated and designed it, and wrote the paper. NC contributed to the data analysis and discussion of the results. LB contributed to the data analysis, managed the dataset, and helped to write the paper. AE assisted in the design of the study and helped to write the paper. PS assisted in the design of the study, was responsible for designing the data analysis, performed the regression analyses, and contributed to the writing of the paper. PS and UÖ are guarantors.
Funding Forsknings-och utvecklingsenheten, Stockholms Läns Landsting. This study was supported by grant 1998 7289 from Stockholm County Council.
Competing interests None declared.